IL141142A0 - Gastrointestinal bacterial antibody factories - Google Patents

Gastrointestinal bacterial antibody factories

Info

Publication number
IL141142A0
IL141142A0 IL14114299A IL14114299A IL141142A0 IL 141142 A0 IL141142 A0 IL 141142A0 IL 14114299 A IL14114299 A IL 14114299A IL 14114299 A IL14114299 A IL 14114299A IL 141142 A0 IL141142 A0 IL 141142A0
Authority
IL
Israel
Prior art keywords
gastrointestinal bacterial
bacterial antibody
antibody factories
factories
gastrointestinal
Prior art date
Application number
IL14114299A
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of IL141142A0 publication Critical patent/IL141142A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14114299A 1998-07-30 1999-07-29 Gastrointestinal bacterial antibody factories IL141142A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9469798P 1998-07-30 1998-07-30
PCT/US1999/017296 WO2000006764A1 (en) 1998-07-30 1999-07-29 Gastrointestinal bacterial antibody factories

Publications (1)

Publication Number Publication Date
IL141142A0 true IL141142A0 (en) 2002-02-10

Family

ID=22246653

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14114299A IL141142A0 (en) 1998-07-30 1999-07-29 Gastrointestinal bacterial antibody factories

Country Status (6)

Country Link
EP (1) EP1100950A4 (en)
JP (1) JP2002521494A (en)
AU (1) AU5328599A (en)
CA (1) CA2338001A1 (en)
IL (1) IL141142A0 (en)
WO (1) WO2000006764A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102336832A (en) 2004-11-25 2012-02-01 荷兰联合利华有限公司 Heavy chain and domain antibodies
MX2008002222A (en) * 2005-08-19 2008-03-25 Unilever Nv Food products comprising probiotic micro-organisms and antibodies.
US20100303777A1 (en) * 2006-12-14 2010-12-02 Actogenix N.V. Delivery of binding molecules to induce immunomodulation
WO2012141540A2 (en) * 2011-04-13 2012-10-18 씨제이제일제당 (주) Novel isolated lactobacillus fermentum strain having viral infection inhibitory activity
CN104428408A (en) * 2012-07-13 2015-03-18 学校法人帝京平成大学 Anti-tumour agent, marker for tumour detection, and oral vaccine agent
CN104736695B (en) * 2012-07-20 2017-05-24 普瑞特克微生物有限责任公司 Non-pathogenic F18 E. coli strain and use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4571385A (en) * 1983-06-27 1986-02-18 The United States Of America As Represented By The Department Of Health And Human Services Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors
EP0198086B1 (en) * 1984-09-28 1991-01-16 Teijin Limited Mouse human hybridoma producing antivirus human antibody, process for its preparation, and antivirus human monoclonal antibody
US4956452A (en) * 1987-06-14 1990-09-11 The University Of Maryland Monoclonal antibody which neutralizes multiple strains of infectious bursal disease virus
US5637677A (en) * 1987-07-16 1997-06-10 The Trustees Of The University Of Pennsylvania Biologically active compounds and methods of constructing and using the same
WO1994021284A1 (en) * 1993-03-15 1994-09-29 Pharma Pacific Pty. Ltd. Therapeutic formulation and method
US5531988A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Bacteria and immunoglobulin-containing composition for human gastrointestinal health
US5733540A (en) * 1995-03-08 1998-03-31 Lee; Peter Poon-Hang Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
AUPN698495A0 (en) * 1995-12-06 1996-01-04 Pharma Pacific Pty Ltd Improved therapeutic formulation and method
US5895758A (en) * 1997-06-10 1999-04-20 Bio-Energy Systems Strain of lactobacillus Plantarum

Also Published As

Publication number Publication date
JP2002521494A (en) 2002-07-16
EP1100950A1 (en) 2001-05-23
AU5328599A (en) 2000-02-21
WO2000006764A1 (en) 2000-02-10
EP1100950A4 (en) 2002-10-16
CA2338001A1 (en) 2000-02-10

Similar Documents

Publication Publication Date Title
GB9809839D0 (en) Antibody
PT2261358E (en) Novel streptococcus antigen
GB9911569D0 (en) Antibodies
ZA991272B (en) Novel thiobenzamides.
GB9808145D0 (en) Assay
IL141142A0 (en) Gastrointestinal bacterial antibody factories
GB9818915D0 (en) Antibodies
GB9828700D0 (en) Antibody
GB9803156D0 (en) Assay
GB9809160D0 (en) Assay
GB9825184D0 (en) Antigen
GB9819411D0 (en) Antibodies
GB9827845D0 (en) Immunoassay or proteins
KR200203130Y1 (en) Apartment
GB9800760D0 (en) Antigens
GB9816327D0 (en) Antibody
ZA983532B (en) Sensors.
GB9816280D0 (en) Antibody combination
GB9817097D0 (en) Gastrointestinal function
AUPP160198A0 (en) Prefabricated factories
GB9822143D0 (en) Antigens
GB9819015D0 (en) Antigens
GB9804779D0 (en) Chemical modification
GB9812533D0 (en) Bacterial protein
GB9815305D0 (en) Elelctrochemical sensors